CLOVER HEALTH INVESTMENTS CORP

NASDAQ: CLOV (Clover Health Investments, Corp)

最近更新时间: 25 Sep, 5:02PM

3.16

-0.06 (-1.86%)

前收盘价格 3.22
收盘价格 3.15
成交量 6,752,532
平均成交量 (3个月) 8,807,136
市值 1,619,539,712
预期市盈率 (P/E Forward) 37.74
价格/销量 (P/S) 0.790
股市价格/股市净资产 (P/B) 3.77
52周波幅
2.12 (-32%) — 4.87 (54%)
利润日期 5 Nov 2025
营业毛利率 -1.69%
营业利益率 (TTM) -0.28%
稀释每股收益 (EPS TTM) -0.040
季度收入增长率 (YOY) 33.40%
总债务/股东权益 (D/E MRQ) 1.07%
流动比率 (MRQ) 1.54
营业现金流 (OCF TTM) -7.38 M
杠杆自由现金流 (LFCF TTM) 126.31 M
资产报酬率 (ROA TTM) -2.43%
股东权益报酬率 (ROE TTM) -7.75%

市场趋势

短期 中期
行业 Healthcare Plans (US) 看涨 混合的
Healthcare Plans (全球的) 看涨 混合的
股票 Clover Health Investments, Corp 看跌 看涨

AIStockmoo 评分

-0.7
分析师共识 -0.5
内部交易活动 -3.0
价格波动 -2.0
技术平均移动指标 2.5
技术振荡指标 -0.5
平均 -0.70

相关股票

股票 市值 DY P/E(TTM) P/B
CLOV 2 B - - 3.77
MRAI 19 M - - 1.49
ALHC 3 B - - 22.55

Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.

部门 Healthcare
行业 Healthcare Plans
投资方式 Small Value
内部持股比例 3.90%
机构持股比例 26.16%
52周波幅
2.12 (-32%) — 4.87 (54%)
目标价格波幅
3.00 (-5%) — 4.10 (29%)
4.10 (Canaccord Genuity, 29.75%) 购买
3.55 (12.34%)
3.00 (UBS, -5.06%) 保留
平均值 3.55 (12.34%)
总计 1 购买, 1 保留
平均价格@调整类型 2.24
公司 日期 目标价格 调整类型 价格@调整类型
Canaccord Genuity 07 Aug 2025 4.10 (29.75%) 购买 2.21
UBS 06 Aug 2025 3.00 (-5.06%) 保留 2.26
名称 平均购买 ($) 平均卖出 ($) 总净额 总净值 ($)
TOY ANDREW - 2.62 -308,950 -809,449
累积净数量 -308,950
累积净值 ($) -809,449
累积平均购买 ($) -
累积平均卖出 ($) 2.62
名称 持有人 日期 类型 数量 价格 价值 ($)
TOY ANDREW 职员 01 Oct 2025 处理 (-) 308,950 2.62 809,449
日期 类型 细节
07 Oct 2025 公告 Clover Health to Report Third Quarter 2025 Financial Results on November 4, 2025
06 Oct 2025 公告 Counterpart Health Expands Leadership to Accelerate Enterprise Partnerships and Regional Adoption of AI-Powered Platform Counterpart Assistant
25 Sep 2025 公告 Counterpart Assistant Gets Conversational
18 Sep 2025 公告 Clover Health Celebrates the Election of Dr. Ian Duncan, Clover MA Board Member, as the 2025-2026 President-Elect and Vice-Chair of the Society of Actuaries
16 Sep 2025 公告 Clover Health Launches New Portal Availity® Essentials™ to Empower Providers and Improve the Patient Experience
09 Sep 2025 公告 Counterpart Health Launches Integrated Scribing, Supercharging Counterpart Assistant with Smarter, Seamless Scribing Built for Value-Based Care
03 Sep 2025 公告 Clover Health CEO Andrew Toy Testifies Before Congress on the Transformative Role of AI in Healthcare, Highlights how Clover is Leading the Way
04 Aug 2025 公告 Primary Care Physician Use of Counterpart Assistant Technology Linked to Better Health Outcomes in Patients with Chronic Obstructive Pulmonary Disease
31 Jul 2025 公告 Clover Health Applauds White House and CMS’ Push to “Tear Down Digital Walls,” Accelerating and Simplifying Access to Health Data for Patients and Their Clinicians
29 Jul 2025 公告 Counterpart Health Appoints Vicky Bruner as Vice President of Operations to Support Expansion and Customer Execution
21 Jul 2025 公告 Clover Health to Participate in Upcoming Canaccord Genuity 45th Annual Growth Conference
17 Jul 2025 公告 Clover Health Appoints Joseph Oldakowski as Vice President of Finance and Controller
显示更多

支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。

投资组合

AI 建议策略模板

自定义的价格提醒

风险概况

| | | | |
很保守
适度保守
中等
中等风险
激进风险
安全边际 (EP)
部分利润 (TP1)
目标利润 (TP2)
最大损失 (SL)

免责声明:以上内容仅供参考,并非投资建议。请咨询合格的财务顾问。

开始购买价格 (EP)

第一个目标价格赚取利润 (TP1)

第二个目标价格赚取利润 (TP2)

停止损失价格 (SL)

52周波幅范围
 
52WL
 
52WH
SL
EP
TP1
TP2

所有提醒价格都在52周波幅范围内

已实现利润 -
未实现利润 -
收到股息 2025 -
利润总额 -
平均回报 -
数量(购买) -
平均价格(购买) -
数量(卖出) -
平均价格(卖出) -
没有符合您标准的股票